Eflornithine

Eflornithine is a drug developed by Aventis while looking at anti cancer medication. While ineffective at fighting cancer it was found to be effective in combatting sleeping sickness in particular the West African form. It could replace the highly toxic Melarsoprol. Supplies of Eflornithine are limited as Aventis no longer manufactures it due to low profit margins. Aventis gave the patent to the WHO who attempted to find a new supplier. The drug has also been shown to be an effective hair growth retardant in some patients, and is sold under the brand name Vaniqa (eflornithine hydrochloride 13.9%)

 

<< PreviousWord BrowserNext >>
2002 in baseball
izidor guzmics
national housing act (canada)
knickerbocker holiday
frontier (computer game)
orca air
scott foley
sourashtra
william hooper councill
rob moroso
street scene
dronology
james hadley
guy berryman
vancouver symphony orchestra
warner independent productions
shiri (race)
ian gregson
jonathan norcross
we vs. death
stabsscharfhrer
darro
giovanni guidiccioni
huff duff
toronto municipal election, 2003
binkered
robin dunne
toronto municipal election, 2000
hammerbeam roof
david antin
tyne valley line
armalite ar50
bananafish
huron wind
michael john lachiusa
fstbroera saga
louisville fire
divri
trollinger
irish home rule bill
list of toronto municipal elections
talbot memorial bridge
across the wall
nicole bilderback